Abstract
A traditional view of cellular differentiation is unidirectional: progenitor cells adopt specific fates in response to environmental cues resulting in deployment of cell-specific gene expression programs and acquisition of unique differentiated cellular properties such as production of structural and functional proteins that define individual cell types. In both development and in tissue repair stem and progenitor cells are thought to both self-renew to maintain the pool of precursors and to expand to give rise to transient amplifying and differentiated cell types. Recently, however, it has become appreciated that differentiated cell types can be reprogrammed to adopt progenitor and stem cell properties. In the case of epithelial cells in the mammalian liver, hepatocytes and biliary epithelial cells there is a significant degree of plasticity between these lineages that has been implicated in mechanisms of tissue repair and in liver pathologies such as cancer. Recent studies have highlighted the role of Hippo signaling, an emerging growth control and tumor suppressor pathway, in regulating epithelial cell plasticity in the mammalian liver and in this review, the role of cellular plasticity and Hippo signaling in regulating normal and abnormal tissue responses in the mammalian liver will be discussed.
Similar content being viewed by others
References
Alder, O., Cullum, R., Lee, S., Kan, A.C., Wei, W., Yi, Y., Garside, V.C., Bilenky, M., Griffith, M., Morrissy, A.S., et al. (2014). Hippo signaling influences HNF4A and FOXA2 enhancer switching during hepatocyte differentiation. Cell Rep 9, 261–271.
Ally, A., Balasundaram, M., Carlsen, R., Chuah, E., Clarke, A., Dhalla, N., Holt, R.A., Jones, S.J.M., Lee, D., Ma, Y., et al. (2017). Comprehensive and integrative genomic characterization of hepatocellular carcinoma. Cell 169, 1327–1341.e23.
Alwahsh, S.M., Rashidi, H., and Hay, D.C. (2018). Liver cell therapy: is this the end of the beginning? Cell Mol Life Sci 75, 1307–1324.
Bai, H., Zhang, N., Xu, Y., Chen, Q., Khan, M., Potter, J.J., Nayar, S.K., Cornish, T., Alpini, G., Bronk, S., et al. (2012). Yes-associated protein regulates the hepatic response after bile duct ligation. Hepatology 56, 1097–1107.
Cai, W.Y., Lin, L.Y., Hao, H., Zhang, S.M., Ma, F., Hong, X.X., Zhang, H., Liu, Q.F., Ye, G.D., Sun, G.B., et al. (2017). Yes-associated protein/TEA domain family member and hepatocyte nuclear factor 4-alpha (HNF4α) repress reciprocally to regulate hepatocarcinogenesis in rats and mice. Hepatology 65, 1206–1221.
Chen, J., Chen, L., Zern, M.A., Theise, N.D., Diehl, A.M., Liu, P., and Duan, Y. (2017). The diversity and plasticity of adult hepatic progenitor cells and their niche. Liver international: official journal of the International Association for the Study of the Liver 37, 1260–1271.
Choi, T.Y., Ninov, N., Stainier, D.Y.R., and Shin, D. (2014). Extensive conversion of hepatic biliary epithelial cells to hepatocytes after near total loss of hepatocytes in zebrafish. Gastroenterology 146, 776–788.
Dorrell, C., Erker, L., Schug, J., Kopp, J.L., Canaday, P.S., Fox, A.J., Smirnova, O., Duncan, A.W., Finegold, M.J., Sander, M., et al. (2011). Prospective isolation of a bipotential clonogenic liver progenitor cell in adult mice. Genes Dev 25, 1193–1203.
Duncan, A.W., Dorrell, C., and Grompe, M. (2009). Stem cells and liver regeneration. Gastroenterology 137, 466–481.
Español-Suñer, R., Carpentier, R., Van Hul, N., Legry, V., Achouri, Y., Cordi, S., Jacquemin, P., Lemaigre, F., and Leclercq, I.A. (2012). Liver progenitor cells yield functional hepatocytes in response to chronic liver injury in mice. Gastroenterology 143, 1564–1575.e7.
Fan, B., Malato, Y., Calvisi, D.F., Naqvi, S., Razumilava, N., Ribback, S., Gores, G.J., Dombrowski, F., Evert, M., Chen, X., et al. (2012). Cholangiocarcinomas can originate from hepatocytes in mice. J Clin Invest 122, 2911–2915.
Fausto, N. (2004). Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology 39, 1477–1487.
Font-Burgada, J., Shalapour, S., Ramaswamy, S., Hsueh, B., Rossell, D., Umemura, A., Taniguchi, K., Nakagawa, H., Valasek, M.A., Ye, L., et al. (2015). Hybrid periportal hepatocytes regenerate the injured liver without giving rise to cancer. Cell 162, 766–779.
Furuyama, K., Kawaguchi, Y., Akiyama, H., Horiguchi, M., Kodama, S., Kuhara, T., Hosokawa, S., Elbahrawy, A., Soeda, T., Koizumi, M., et al. (2011). Continuous cell supply from a Sox9-expressing progenitor zone in adult liver, exocrine pancreas and intestine. Nat Genet 43, 34–41.
Grijalva, J.L., Huizenga, M., Mueller, K., Rodriguez, S., Brazzo, J., Camargo, F., Sadri- Vakili, G., and Vakili, K. (2014). Dynamic alterations in Hippo signaling pathway and YAP activation during liver regeneration. Am J Physiol-Gastrointestinal Liver Physiol 307, G196–G204.
Guest, R.V., Boulter, L., Kendall, T.J., Minnis- Lyons, S.E., Walker, R., Wigmore, S.J., Sansom, O.J., and Forbes, S.J. (2014). Cell lineage tracing reveals a biliary origin of intrahepatic cholangiocarcinoma. Cancer Res 74, 1005–1010.
Guo, X., Zhao, Y., Yan, H., Yang, Y., Shen, S., Dai, X., Ji, X., Ji, F., Gong, X.G., Li, L., et al. (2017). Single tumor-initiating cells evade immune clearance by recruiting type II macrophages. Genes Dev 31, 247–259.
Halder, G., and Johnson, R.L. (2011). Hippo signaling: growth control and beyond. Development 138, 9–22.
He, J., Lu, H., Zou, Q., and Luo, L. (2014). Regeneration of liver after extreme hepatocyte loss occurs mainly via biliary transdifferentiation in zebrafish. Gastroenterology 146, 789–800.e8.
Holczbauer, Á., Factor, V.M., Andersen, J.B., Marquardt, J.U., Kleiner, D. E., Raggi, C., Kitade, M., Seo, D., Akita, H., Durkin, M.E., et al. (2013). Modeling pathogenesis of primary liver cancer in lineage-specific mouse cell types. Gastroenterology 145, 221–231.
Huch, M., Gehart, H., van Boxtel, R., Hamer, K., Blokzijl, F., Verstegen, M.M.A., Ellis, E., van Wenum, M., Fuchs, S.A., de Ligt, J., et al. (2015). Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160, 299–312.
Jörs, S., Jeliazkova, P., Ringelhan, M., Thalhammer, J., Dürl, S., Ferrer, J., Sander, M., Heikenwalder, M., Schmid, R.M., Siveke, J.T., et al. (2015). Lineage fate of ductular reactions in liver injury and carcinogenesis. J Clin Invest 125, 2445–2457.
Katsuda, T., Kawamata, M., Hagiwara, K., Takahashi, R.U., Yamamoto, Y., Camargo, F.D., and Ochiya, T. (2017). Conversion of terminally committed hepatocytes to culturable bipotent progenitor cells with regenerative capacity. Cell Stem Cell 20, 41–55.
Kim, W., Khan, S.K., Liu, Y., Xu, R., Park, O., He, Y., Cha, B., Gao, B., and Yang, Y. (2018). Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma. Gut 67, 1692–1703.
Kopp, J.L., Grompe, M., and Sander, M. (2016). Stem cells versus plasticity in liver and pancreas regeneration. Nat Cell Biol 18, 238–245.
Krenkel, O., and Tacke, F. (2017). Liver macrophages in tissue homeostasis and disease. Nat Rev Immunol 17, 306–321.
Kubes, P., and Jenne, C. (2018). Immune responses in the liver. Annu Rev Immunol 36, 247–277.
Lee, D.H., Park, J.O., Kim, T.S., Kim, S.K., Kim, T.H., Kim, M.C., Park, G.S., Kim, J.H., Kuninaka, S., Olson, E.N., et al. (2016). LATS-YAP/TAZ controls lineage specification by regulating TGFβ signaling and Hnf4α expression during liver development. Nat Commun 7, 11961.
Lee, K.P., Lee, J.H., Kim, T.S., Kim, T.H., Park, H.D., Byun, J.S., Kim, M. C., Jeong, W.I., Calvisi, D.F., Kim, J.M., et al. (2010). The HippoSalvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 107, 8248–8253.
Lemoinne, S., Thabut, D., and Housset, C. (2016). Portal myofibroblasts connect angiogenesis and fibrosis in liver. Cell Tissue Res 365, 583–589.
Lin, S., Nascimento, E.M., Gajera, C.R., Chen, L., Neuhöfer, P., Garbuzov, A., Wang, S., and Artandi, S.E. (2018). Distributed hepatocytes expressing telomerase repopulate the liver in homeostasis and injury. Nature 556, 244–248.
Llovet, J.M., Zucman- Rossi, J., Pikarsky, E., Sangro, B., Schwartz, M., Sherman, M., and Gores, G. (2016). Hepatocellular carcinoma. Nat Rev Dis Primers 2, 16018.
Lu, L., Finegold, M.J., and Johnson, R.L. (2018). Hippo pathway coactivators Yap and Taz are required to coordinate mammalian liver regeneration. Exp Mol Med 50, e423.
Lu, L., Li, Y., Kim, S.M., Bossuyt, W., Liu, P., Qiu, Q., Wang, Y., Halder, G., Finegold, M.J., Lee, J.S., et al. (2010). Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 107, 1437–1442.
Lu, W.Y., Bird, T.G., Boulter, L., Tsuchiya, A., Cole, A.M., Hay, T., Guest, R.V., Wojtacha, D., Man, T.Y., Mackinnon, A., et al. (2015). Hepatic progenitor cells of biliary origin with liver repopulation capacity. Nat Cell Biol 17, 971–983.
Machado, M.V., Michelotti, G.A., Pereira, T.A., Xie, G., Premont, R., Cortez- Pinto, H., and Diehl, A.M. (2015). Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease. J Hepatol 63, 962–970.
Malato, Y., Naqvi, S., Schürmann, N., Ng, R., Wang, B., Zape, J., Kay, M. A., Grimm, D., and Willenbring, H. (2011). Fate tracing of mature hepatocytes in mouse liver homeostasis and regeneration. J Clin Invest 121, 4850–4860.
Marquardt, J.U., Andersen, J.B., and Thorgeirsson, S.S. (2015). Functional and genetic deconstruction of the cellular origin in liver cancer. Nat Rev Cancer 15, 653–667.
Michalopoulos, G.K. (2017). Hepatostat: Liver regeneration and normal liver tissue maintenance. Hepatology 65, 1384–1392.
Michalopoulos, G.K., and DeFrances, M.C. (1997). Liver regeneration. Science 276, 60–66.
Mu, X., Español-Suñer, R., Mederacke, I., Affò, S., Manco, R., Sempoux, C., Lemaigre, F.P., Adili, A., Yuan, D., Weber, A., et al. (2015). Hepatocellular carcinoma originates from hepatocytes and not from the progenitor/biliary compartment. J Clin Invest 125, 3891–3903.
Ober, E.A., and Lemaigre, F.P. (2018). Development of the liver: insights into organ and tissue morphogenesis. J Hepatol 68, 1049–1062.
Pan, D. (2010). The Hippo signaling pathway in development and cancer. Dev Cell 19, 491–505.
Patel, S.H., Camargo, F.D., and Yimlamai, D. (2017). Hippo signaling in the liver regulates organ size, cell fate, and carcinogenesis. Gastroenterology 152, 533–545.
Poisson, J., Lemoinne, S., Boulanger, C., Durand, F., Moreau, R., Valla, D., and Rautou, P.E. (2017). Liver sinusoidal endothelial cells: Physiology and role in liver diseases. J Hepatol 66, 212–227.
Raven, A., Lu, W.Y., Man, T.Y., Ferreira- Gonzalez, S., O’ Duibhir, E., Dwyer, B.J., Thomson, J.P., Meehan, R.R., Bogorad, R., Koteliansky, V., et al. (2017). Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature 547, 350–354.
Schaub, J.R., Malato, Y., Gormond, C., and Willenbring, H. (2014). Evidence against a stem cell origin of new hepatocytes in a common mouse model of chronic liver injury. Cell Rep 8, 933–939.
Schaub, J.R., Huppert, K.A., Kurial, S.N.T., Hsu, B.Y., Cast, A.E., Donnelly, B., Karns, R.A., Chen, F., Rezvani, M., Luu, H.Y., et al. (2018). De novo formation of the biliary system by TGFβ-mediated hepatocyte transdifferentiation. Nature 557, 247–251.
Sekiya, S., and Suzuki, A. (2012). Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes. J Clin Invest 122, 3914–3918.
Shin, S., Walton, G., Aoki, R., Brondell, K., Schug, J., Fox, A., Smirnova, O., Dorrell, C., Erker, L., Chu, A.S., et al. (2011). Foxl1-Cre-marked adult hepatic progenitors have clonogenic and bilineage differentiation potential. Genes Dev 25, 1185–1192.
Shin, S., Wangensteen, K.J., Teta- Bissett, M., Wang, Y.J., Mosleh- Shirazi, E., Buza, E.L., Greenbaum, L.E., and Kaestner, K.H. (2016). Genetic lineage tracing analysis of the cell of origin of hepatotoxin-induced liver tumors in mice. Hepatology 64, 1163–1177.
Si-Tayeb, K., Lemaigre, F.P., and Duncan, S.A. (2010). Organogenesis and development of the liver. Dev Cell 18, 175–189.
Stanger, B.Z. (2015). Cellular homeostasis and repair in the mammalian liver. Annu Rev Physiol 77, 179–200.
Suzuki, A., Sekiya, S., Onishi, M., Oshima, N., Kiyonari, H., Nakauchi, H., and Taniguchi, H. (2008). Flow cytometric isolation and clonal identification of self-renewing bipotent hepatic progenitor cells in adult mouse liver. Hepatology 48, 1964–1978.
Tanaka, M., and Iwakiri, Y. (2016). The hepatic lymphatic vascular system: structure, function, markers, and lymphangiogenesis. Cell Mol Gastroenterol Hepatol 2, 733–749.
Tarlow, B.D., Finegold, M.J., and Grompe, M. (2014a). Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury. Hepatology 60, 278–289.
Tarlow, B.D., Pelz, C., Naugler, W.E., Wakefield, L., Wilson, E.M., Finegold, M.J., and Grompe, M. (2014b). Bipotential adult liver progenitors are derived from chronically injured mature hepatocytes. Cell Stem Cell 15, 605–618.
Theise, N.D., Saxena, R., Portmann, B.C., Thung, S.N., Yee, H., Chiriboga, L., Kumar, A., and Crawford, J.M. (1999). The canals of Hering and hepatic stem cells in humans. Hepatology 30, 1425–1433.
Tolosa, L., Pareja, E., and Gomez-Lechon, M.J. (2016). Clinical application of pluripotent stem cells: an alternative cell-based therapy for treating liver diseases? Transplantation 100, 2548–2557.
Tschaharganeh, D.F., Xue, W., Calvisi, D.F., Evert, M., Michurina, T.V., Dow, L.E., Banito, A., Katz, S.F., Kastenhuber, E.R., Weissmueller, S., et al. (2016). p53-Dependent Nestin regulation links tumor suppression to cellular plasticity in liver cancer. Cell 165, 1546–1547.
Tsuchida, T., and Friedman, S.L. (2017). Mechanisms of hepatic stellate cell activation. Nat Rev Gastroenterol Hepatol 14, 397–411.
Wang, B., Zhao, L., Fish, M., Logan, C.Y., and Nusse, R. (2015). Self-renewing diploid Axin2+ cells fuel homeostatic renewal of the liver. Nature 524, 180–185.
Wang, X., Foster, M., Al- Dhalimy, M., Lagasse, E., Finegold, M., and Grompe, M. (2003). The origin and liver repopulating capacity of murine oval cells. Proc Natl Acad Sci USA 100(Suppl 1), 11881–11888.
Wang, X., Zheng, Z., Caviglia, J.M., Corey, K.E., Herfel, T.M., Cai, B., Masia, R., Chung, R.T., Lefkowitch, J.H., Schwabe, R.F., et al. (2016). Hepatocyte TAZ/WWTR1 promotes inflammation and fibrosis in nonalcoholic steatohepatitis. Cell Metab 24, 848–862.
Wu, H., Zhou, X., Fu, G.B., He, Z.Y., Wu, H.P., You, P., Ashton, C., Wang, X., Wang, H.Y., and Yan, H.X. (2017). Reversible transition between hepatocytes and liver progenitors for in vitro hepatocyte expansion. Cell Res 27, 709–712.
Xu, M.Z., Yao, T.J., Lee, N.P.Y., Ng, I.O.L., Chan, Y.T., Zender, L., Lowe, S.W., Poon, R.T.P., and Luk, J.M. (2009). Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576–4585.
Yang, L., Wang, W.H., Qiu, W.L., Guo, Z., Bi, E., and Xu, C.R. (2017). A single-cell transcriptomic analysis reveals precise pathways and regulatory mechanisms underlying hepatoblast differentiation. Hepatology 66, 1387–1401.
Yanger, K., Knigin, D., Zong, Y., Maggs, L., Gu, G., Akiyama, H., Pikarsky, E., and Stanger, B.Z. (2014). Adult hepatocytes are generated by self-duplication rather than stem cell differentiation. Cell Stem Cell 15, 340–349.
Yanger, K., and Stanger, B.Z. (2011). Facultative stem cells in liver and pancreas: fact and fancy. Dev Dyn 240, 521–529.
Yanger, K., Zong, Y., Maggs, L.R., Shapira, S.N., Maddipati, R., Aiello, N. M., Thung, S.N., Wells, R.G., Greenbaum, L.E., and Stanger, B.Z. (2013). Robust cellular reprogramming occurs spontaneously during liver regeneration. Genes Dev 27, 719–724.
Yi, J., Lu, L., Yanger, K., Wang, W., Sohn, B.H., Stanger, B.Z., Zhang, M., Martin, J.F., Ajani, J.A., Chen, J., et al. (2016). Large tumor suppressor homologs 1 and 2 regulate mouse liver progenitor cell proliferation and maturation through antagonism of the coactivators YAP and TAZ. Hepatology 64, 1757–1772.
Yimlamai, D., Christodoulou, C., Galli, G.G., Yanger, K., Pepe- Mooney, B., Gurung, B., Shrestha, K., Cahan, P., Stanger, B.Z., and Camargo, F. D. (2014). Hippo pathway activity influences liver cell fate. Cell 157, 1324–1338.
Yoo, K.S., Lim, W.T., and Choi, H.S. (2016). Biology of cholangiocytes: from bench to bedside. Gut Liver 10, 687–698.
Yovchev, M., Jaber, F.L., Lu, Z., Patel, S., Locker, J., Rogler, L.E., Murray, J.W., Sudol, M., Dabeva, M.D., Zhu, L., et al. (2016). Experimental model for successful liver cell therapy by Lenti TTR-YapERT2 transduced hepatocytes with tamoxifen control of Yap subcellular location. Sci Rep 6, 19275.
Zajicek, G., Oren, R., and Weinreb Jr., M. (1985). The streaming liver. Liver 5, 293–300.
Zhang, T., Zhang, J., You, X., Liu, Q., Du, Y., Gao, Y., Shan, C., Kong, G., Wang, Y., Yang, X., et al. (2012). Hepatitis B virus X protein modulates oncogene Yes-associated protein by CREB to promote growth of hepatoma cells. Hepatology 56, 2051–2059.
Acknowledgements
This work was supported by the Cancer Prevention and Research Institute of Texas (CPRIT) Award RP180530.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Compliance and ethics The author(s) declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Johnson, R.L. Hippo signaling and epithelial cell plasticity in mammalian liver development, homeostasis, injury and disease. Sci. China Life Sci. 62, 1609–1616 (2019). https://doi.org/10.1007/s11427-018-9510-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11427-018-9510-3